AIDS-defining illnesses in the active study population
Study . | Date . | CD4, × 109/L (%) . | Diagnosis . |
|---|---|---|---|
| msc IL-2 | November 1998 | 0.543 (33) | Mild HIV encephalopathy, NARS 1 |
| sc 500 | January 1996 | 1.041 (49) | Cutaneous Kaposi sarcoma with multiple recurrences, first diagnosis with CD4 1082 (44%) |
| sc IL-2 | April 1999 | 0.209 (18) | Cutaneous Kaposi sarcoma |
| sc 500 | December 1999 | 1.565 (46) | Non-Hodgkin lymphoma, right lower quadrant mass |
Study . | Date . | CD4, × 109/L (%) . | Diagnosis . |
|---|---|---|---|
| msc IL-2 | November 1998 | 0.543 (33) | Mild HIV encephalopathy, NARS 1 |
| sc 500 | January 1996 | 1.041 (49) | Cutaneous Kaposi sarcoma with multiple recurrences, first diagnosis with CD4 1082 (44%) |
| sc IL-2 | April 1999 | 0.209 (18) | Cutaneous Kaposi sarcoma |
| sc 500 | December 1999 | 1.565 (46) | Non-Hodgkin lymphoma, right lower quadrant mass |
NARS refers to the Neuropsychiatric AIDS Rating Scale.